AR246255A1 - Procedimiento de preparacion de ((difenil-metoxi)-alquil l)-1-pirrolidinas y piperidinas. - Google Patents
Procedimiento de preparacion de ((difenil-metoxi)-alquil l)-1-pirrolidinas y piperidinas.Info
- Publication number
- AR246255A1 AR246255A1 AR89314972A AR31497289A AR246255A1 AR 246255 A1 AR246255 A1 AR 246255A1 AR 89314972 A AR89314972 A AR 89314972A AR 31497289 A AR31497289 A AR 31497289A AR 246255 A1 AR246255 A1 AR 246255A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- piperidines
- preparation
- pyrrolidines
- diaryl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
- C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
- C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
-
- H—ELECTRICITY
- H03—ELECTRONIC CIRCUITRY
- H03H—IMPEDANCE NETWORKS, e.g. RESONANT CIRCUITS; RESONATORS
- H03H7/00—Multiple-port networks comprising only passive electrical elements as network components
- H03H7/01—Frequency selective two-port networks
- H03H7/09—Filters comprising mutual inductance
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyrrole Compounds (AREA)
Abstract
PREPARACION DE ((DIFENILMETOXI)ALQUIL)-1-PIRROLIDINAS Y PIPERIDINAS DE FORMULA (I), DONDE X ES HIDROGENO O FLUOR, ALK ES ALQUILO; R1 Y R2 SON HIDROGENO O ALCOXI; N ES 4 O 5, POR CONDENSACION DE UN DERIVADO DE FORMULA (II) CON UNA FENILPIRROLIDINA O UNA FENILPIPERIDINA DE FORMULA (III), CON UN AGENTE ALCALINO COMO SER CARBONATOS O HIDRUROS DE SODIO Y POTASIO, EN UN SOLVENTE INERTE.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR8812430A FR2636946B1 (fr) | 1988-09-23 | 1988-09-23 | ((diarylmethoxy)alcoyl)-1 pyrrolidines et piperidines, procedes de preparation et medicaments les contenant |
Publications (1)
Publication Number | Publication Date |
---|---|
AR246255A1 true AR246255A1 (es) | 1994-07-29 |
Family
ID=9370298
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AR89314972A AR246255A1 (es) | 1988-09-23 | 1989-09-20 | Procedimiento de preparacion de ((difenil-metoxi)-alquil l)-1-pirrolidinas y piperidinas. |
Country Status (25)
Country | Link |
---|---|
US (1) | US4957927A (es) |
EP (1) | EP0360685B1 (es) |
JP (1) | JPH02121964A (es) |
AR (1) | AR246255A1 (es) |
AT (1) | ATE101132T1 (es) |
AU (1) | AU617530B2 (es) |
CA (1) | CA1327364C (es) |
CZ (1) | CZ279282B6 (es) |
DD (1) | DD284875A5 (es) |
DE (1) | DE68912860T2 (es) |
DK (1) | DK468389A (es) |
ES (1) | ES2062071T3 (es) |
FR (1) | FR2636946B1 (es) |
HU (1) | HU208422B (es) |
IE (1) | IE63648B1 (es) |
IL (1) | IL91689A0 (es) |
MA (1) | MA21631A1 (es) |
NO (1) | NO893764L (es) |
NZ (1) | NZ230744A (es) |
OA (1) | OA09135A (es) |
PT (1) | PT91783B (es) |
SU (1) | SU1757462A3 (es) |
TN (1) | TNSN89103A1 (es) |
YU (1) | YU170189A (es) |
ZA (1) | ZA897212B (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX9100513A (es) * | 1990-08-06 | 1992-04-01 | Smith Kline French Lab | Compuestos |
IE912760A1 (en) * | 1990-08-06 | 1992-02-12 | Smith Kline French Lab | Compounds |
CA2038066A1 (en) * | 1990-08-09 | 1992-02-10 | Hiroshi Fukumi | (benzhydryloxyethylpiperidyl) aliphatic acid derivatives and their use in the treatment of allergies and asthma |
GB9113031D0 (en) * | 1991-06-17 | 1991-08-07 | Smithkline Beecham Plc | Compounds |
US5578639A (en) * | 1994-07-01 | 1996-11-26 | Warner-Lambert Company | PLA2 inhibitors and their use for inhibition of intestinal cholesterol absorption |
US6201124B1 (en) | 1995-12-21 | 2001-03-13 | Albany Molecular Research, Inc. | Process for production of piperidine derivatives |
US6153754A (en) * | 1995-12-21 | 2000-11-28 | Albany Molecular Research, Inc. | Process for production of piperidine derivatives |
US5747523A (en) * | 1996-01-24 | 1998-05-05 | Guilford Pharmaceuticals Inc. | Substituted ethyl α,α-diarylmethyl ether derivatives |
US6011035A (en) * | 1998-06-30 | 2000-01-04 | Neuromed Technologies Inc. | Calcium channel blockers |
EP1165508B1 (en) * | 1999-04-07 | 2004-06-23 | The University of Virginia Patent Foundation | Anticancer calcium channel blockers |
US6946475B1 (en) | 1999-04-07 | 2005-09-20 | University Of Virginia Patent Foundation | Anticancer calcium channel blockers |
JP2006512278A (ja) * | 2001-06-13 | 2006-04-13 | テバ ファーマシューティカル インダストリーズ リミティド | アルコキシ不純物を実質的に含有しないパロキセチンの製造方法 |
US9427429B2 (en) | 2010-03-01 | 2016-08-30 | Tau Therapeutics Llc | Cancer diagnosis and imaging |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1545094A (en) * | 1976-12-14 | 1979-05-02 | Gist Brocades Nv | Piperazine derivatives |
-
1988
- 1988-09-23 FR FR8812430A patent/FR2636946B1/fr not_active Expired - Lifetime
-
1989
- 1989-09-06 YU YU01701/89A patent/YU170189A/xx unknown
- 1989-09-19 EP EP89402561A patent/EP0360685B1/fr not_active Expired - Lifetime
- 1989-09-19 IL IL91689A patent/IL91689A0/xx not_active IP Right Cessation
- 1989-09-19 DE DE68912860T patent/DE68912860T2/de not_active Expired - Fee Related
- 1989-09-19 ES ES89402561T patent/ES2062071T3/es not_active Expired - Lifetime
- 1989-09-19 AT AT89402561T patent/ATE101132T1/de not_active IP Right Cessation
- 1989-09-20 AR AR89314972A patent/AR246255A1/es active
- 1989-09-20 JP JP1242360A patent/JPH02121964A/ja active Pending
- 1989-09-20 MA MA21885A patent/MA21631A1/fr unknown
- 1989-09-21 ZA ZA897212A patent/ZA897212B/xx unknown
- 1989-09-22 CA CA000612673A patent/CA1327364C/fr not_active Expired - Fee Related
- 1989-09-22 DD DD89332899A patent/DD284875A5/de not_active IP Right Cessation
- 1989-09-22 DK DK468389A patent/DK468389A/da not_active Application Discontinuation
- 1989-09-22 SU SU894742008A patent/SU1757462A3/ru active
- 1989-09-22 NZ NZ230744A patent/NZ230744A/en unknown
- 1989-09-22 HU HU894981A patent/HU208422B/hu not_active IP Right Cessation
- 1989-09-22 TN TNTNSN89103A patent/TNSN89103A1/fr unknown
- 1989-09-22 IE IE305089A patent/IE63648B1/en not_active IP Right Cessation
- 1989-09-22 AU AU41690/89A patent/AU617530B2/en not_active Ceased
- 1989-09-22 CZ CS895409A patent/CZ279282B6/cs unknown
- 1989-09-22 US US07/410,705 patent/US4957927A/en not_active Expired - Fee Related
- 1989-09-22 PT PT91783A patent/PT91783B/pt not_active IP Right Cessation
- 1989-09-22 NO NO89893764A patent/NO893764L/no unknown
- 1989-09-22 OA OA59651A patent/OA09135A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
IE893050L (en) | 1990-03-23 |
ATE101132T1 (de) | 1994-02-15 |
IE63648B1 (en) | 1995-05-31 |
CZ540989A3 (en) | 1994-11-16 |
HUT52049A (en) | 1990-06-28 |
DK468389D0 (da) | 1989-09-22 |
ES2062071T3 (es) | 1994-12-16 |
CZ279282B6 (cs) | 1995-04-12 |
EP0360685A1 (fr) | 1990-03-28 |
DE68912860T2 (de) | 1994-08-11 |
EP0360685B1 (fr) | 1994-02-02 |
NO893764L (no) | 1990-03-26 |
SU1757462A3 (ru) | 1992-08-23 |
HU208422B (en) | 1993-10-28 |
FR2636946A1 (fr) | 1990-03-30 |
AU4169089A (en) | 1990-03-29 |
TNSN89103A1 (fr) | 1991-02-04 |
AU617530B2 (en) | 1991-11-28 |
PT91783B (pt) | 1995-08-09 |
MA21631A1 (fr) | 1990-04-01 |
DD284875A5 (de) | 1990-11-28 |
IL91689A0 (en) | 1990-06-10 |
ZA897212B (en) | 1991-03-27 |
PT91783A (pt) | 1990-03-30 |
DK468389A (da) | 1990-03-24 |
NZ230744A (en) | 1991-06-25 |
DE68912860D1 (de) | 1994-03-17 |
YU170189A (en) | 1991-02-28 |
OA09135A (fr) | 1991-10-31 |
NO893764D0 (no) | 1989-09-22 |
CA1327364C (fr) | 1994-03-01 |
JPH02121964A (ja) | 1990-05-09 |
US4957927A (en) | 1990-09-18 |
FR2636946B1 (fr) | 1990-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR246255A1 (es) | Procedimiento de preparacion de ((difenil-metoxi)-alquil l)-1-pirrolidinas y piperidinas. | |
AR245718A1 (es) | Procedimiento para preparar un compuesto de imidazo (4,5-b)-piridina | |
ES2103416T3 (es) | Compuesto de piperidina y composicion de material polimero estabilizada que contiene el mismo. | |
AR247213A1 (es) | Preparacion de acido 7-¡(1-carboxi-3-fenilpropil)amino¿-3,4,6,7,8,12b-octahidro-6-oxopirido ¡2,1-a¿ o hexahidro-6-oxo-1h(1,4-tiazino¡3,4-a¿¡2¿-benzazepin-4-carboxilico, agentes hipertensivos. | |
ES2022449B3 (es) | Composiciones de frita de vidrio libre de plomo. | |
ATE36699T1 (de) | Chinonderivate, verfahren zu ihrer herstellung, ihre verwendung und pharmazeutische zusammensetzung. | |
ES8503667A1 (es) | Un procedimiento para la preparacion de nuevos derivados de 2-oxo-imidazolina. | |
AR241019A2 (es) | "procedimiento para separar el grupo alilo de compuestos de carba-penem-carboxilatos de alilo para formar los correspondientes compuestos con el grupo carboxilo libre". | |
HUT41751A (en) | Process for producing pharmaceutical compositions containing 3-amino-sidnonimine derivatives and the active agents | |
ZA912618B (en) | 3-aminochroman derivatives,process for preparing these and pharmaceutical compositions containing them | |
HUT44995A (en) | Insecticide compositions containing alkene compounds as active components and process for producing the active components | |
JPS54160371A (en) | Novel piperidine derivative and hypotensive agents comprising it | |
MY102134A (en) | A novel ether compound, a process for manufacturing the same, a composition containing the same and a use thereof. | |
HU891559D0 (en) | Process for producing 1,3-thiazolidine-beta-carbonyl-carboxy-amides and pharmaceutical preparatives containing them | |
NO177484C (no) | Fremgangsmåte for fremstilling av et farmasöytisk preparat i form av myke kapsler | |
AU610173B2 (en) | New spiro (4,5) decane derivatives, process for the preparation thereof, and pharmaceutical compositions containing them | |
ES2092466T3 (es) | Estabilizadores de la luz de aminas reactivas con impedimento esterico. | |
HRP960369B1 (en) | Process for the preparation of epoxide | |
ES2073482T3 (es) | Derivados de imidazoquinolona. | |
IL64927A0 (en) | Bis-and poly-disulfides,their production and pharmaceutical compositions containing them | |
PT80787A (en) | Process for preparing piperidine (or pyrrolidine)-butanamides and compounds relating to them | |
DE3264556D1 (en) | Sulfimines, their salts and their preparation, and pharmaceutical compositions containing them | |
KR850008160A (ko) | 이미다졸 유도체의 제조방법 | |
IT1197841B (it) | Derivati pirido-benzotiazinici ad attivita' antibatterica ed a lunga durata di azione | |
CH610585A5 (en) | Process for producing new aryl ethers |